Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin–based anticoagulation in intensive care patients on extracorporeal membrane oxygenation

Anaesthesia and Intensive Care

Volumn 44, Issue 1, 2016, Pages 85-92

  Prakash, S ^a   Wiersema, U F ^a   Bihari, S ^a   Roxby, D ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

extracorporeal membrane oxygenation; heparin; partial thromboplastin time; point of care systems; thromboelastometry

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ADULT; BLOOD CLOTTING TIME; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INTENSIVE CARE; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; RETROSPECTIVE STUDY;

ADULT; ANTICOAGULANTS; CRITICAL CARE; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; RETROSPECTIVE STUDIES; WHOLE BLOOD COAGULATION TIME;

EID: 85004143355     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057X1604400113     Document Type: Article

References (31)

1. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009; 13:154-175.
2. Lequier L, Annich G, Al-Ibrahim O, Bembea M, Brodie D, Brogan T et al. ELSO Anticoagulation Guideline. Ann Arbor, MI, USA: ELSO, 2014. From https://www.elso.org/Portals/0/Files/elsoanticoagulationguideline8-2014.pdf. Accessed February 2015.
3. Bembea MM, Annich G, Rycus P, Oldenburg G, Berkowitz I, Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med 2013; 14:e77-e84.
4. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med 2009; 35:2105-2114.
5. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302:1888-1895.
6. Baird CW, Zurakowski D, Robinson B, Gandhi S, Burdis-Koch L, Tamblyn J et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. Ann Thorac Surg 2007; 83:912-919.
7. Esper SA, Levy JH, Waters JH, Welsby IJ. Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. Anesth Analg 2014; 118:731-743.
8. Bembea MM, Schwartz JM, Shah N, Colantuoni E, Lehmann CU, Kickler T et al. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J 2013; 59:63-68.
9. Reiner JS, Coyne KS, Lundergan CF, Ross AM. Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time. Cathet Cardiovasc Diagn 1994; 32:49-52.
10. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Anesthesiology 1994; 80:338-351.
11. Rettmann JA, Markewitz BA, Wilson L, Mayer J, Lehman CM. Concordance of the Activated Partial Thromboplastin Time and the Anti-Activated Factor X Assay in Monitoring Unfractionated Heparin Therapy in Critically Ill Patients. Chest 2004; 126:875S-876S.
12. Nankervis CA, Preston TJ, Dysart KC, Wilkinson WD, Chicoine LG, Welty SE et al. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. ASAIO J 2007; 53:111-114.
13. Agati S, Ciccarello G, Salvo D, Turla G, Undar A, Mignosa C. Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience. ASAIO J 2006; 52:513-516.
14. Zavadil DP, Stammers AH, Willett LD, Deptula JJ, Christensen KA, Sydzyik RT. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol 1998; 30:83-90.
15. Miller BE, Guzzetta NA, Tosone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000; 90:1324-1330.
16. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006; 20:548-553.
17. Schaden E, Jilch S, Hacker S, Schober A, Kozek-Langenecker S. Monitoring of unfractionated heparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent (PiCT(R)). Clin Chim Acta 2012; 414:202-205.
18. Prakash S, Verghese S, Roxby D, Dixon D, Bihari S, Bersten A. Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test--ROTEM. J Crit Care 2015; 30:264-270.
19. Nair P, Hoechter DJ, Buscher H, Venkatesh K, Whittam S, Joseph J et al. Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry. J Cardiothorac Vasc Anesth 2015; 29:288-296.
20. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16:301-310.
21. Bates SM, Weitz JI. Coagulation assays. Circulation 2005; 112:e53-e60.
22. Liveris A, Bello RA, Friedmann P, Duffy MA, Manwani D, Killinger JS et al. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med 2014; 15:e72-e79.
23. Rapaport SI, Vermylen J, Hoylaerts M, Saito H, Hirsh J, Bates S et al. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost 2004; 2:2250-2259.
24. Maul TM, Wolff EL, Kuch BA, Rosendorff A, Morell VO, Wearden PD. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med 2012; 13:e363-e371.
25. Da Luz LT, Nascimento B, Shankarakutty AK, Rizoli S, Adhikari NKJ. Effect of thromboelastography (TEG(R)) and rotational thromboelastometry (ROTEM(R)) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care 2014; 18:518.
26. Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547.
27. Roullet S, Pillot J, Freyburger G, Biais M, Quinart A, Rault A et al. Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation. Br J Anaesth 2010; 104:422-428.
28. Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108:36-41.
29. Ogawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD et al. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012; 52:14-22.
30. Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Trummer G et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med 2012; 38:62-68.
31. Lang T, von Depka M. [Possibilities and limitations of thrombelastometry/-graphy]. Hamostaseologie 2006; 26:S20-S29.